Novel discoveries targeting gemcitabine‐based chemoresistance and new therapies in pancreatic cancer: How far are we from the destination?

Novel discoveries targeting gemcitabine‐based chemoresistance and new therapies in pancreatic cancer: How far are we from the destination?

Abstract Pancreatic cancer (PC) remains one of the deadliest malignancies worldwide. Chemoresistance is a significant clinical problem in pancreatic ductal adenocarcinoma (PDAC) and numerous potential mechanisms have been demonstrated but much remains to be understood. To overcome the existing limit...

Full description

Bibliographic Details
Main Authors: Wenhao Luo, Gang Yang, Jiangdong Qiu, Jingyang Luan, Ying Zhang, Lei You, Mengyu Feng, Fangyu Zhao, Yueze Liu, Zhe Cao, Lianfang Zheng, Taiping Zhang, Yupei Zhao
Format: Article
Language:English
Published: Wiley 2019-10-01
Series:Cancer Medicine
Subjects:
chemistry
drug therapy
metabolism
pancreatic cancer
prevention
Online Access:https://doi.org/10.1002/cam4.2384

Internet

https://doi.org/10.1002/cam4.2384

Similar Items